Company Filing History:

7 out of 290

Les Laboratoires Servier

Les Laboratories Server

patents

Years Active: 1997-2017

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9809553 - Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them (2017-11-07),

2. 8476426 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid (2013-07-02),

3. 8415468 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid (2013-04-09),

4. 8119794 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid (2012-02-21),

5. 8101747 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid (2012-01-24),

6. 8097720 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid (2012-01-17),

7. 8076325 - 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them (2011-12-13),

8. 7612061 - Piperazine compounds (2009-11-03),

9. 6153640 - Benzo[3,4]cyclobuta[1,2-c]pyrrole compounds (2000-11-28),

10. 6107345 - Benzocyclobutane compounds (2000-08-22),

11. 5753662 - Piperazine compounds (1998-05-19),

12. 5726208 - Heterocyclic tertiary amines (1998-03-10),

13. 5684020 - Piperazine, piperidine and 1,2,5,6-tetrahydropyridine (1997-11-04),

14. 5665765 - 5,6,7,8-tetrahydronaphtho[2,3-b]furan and indano[5,6-b]furan amine (1997-09-09),

Title: The Innovations of Aimee Dessinges: A Trailblazer in Pharmaceutical Patents

Introduction

Aimee Dessinges, a prominent inventor based in Rueil Malmaison, France, has made significant contributions to the field of pharmaceuticals through her innovative research and multiple patents. With a total of 14 patents, her work has propelled advancements in medicinal chemistry, particularly in the development of compounds useful for treating serious health conditions.

Latest Patents

Among her latest patents is the development of isoquinoline compounds, along with a detailed process for their preparation and pharmaceutical compositions containing them. These compounds demonstrate potential in treating or preventing pathologies related to the activation of the RhoA/ROCK pathway and the phosphorylation of the myosin light chain. Additionally, Aimee has patented a process for synthesizing ivabradine and its addition salts with pharmaceutically acceptable acids, further showcasing her expertise in pharmaceutical innovations.

Career Highlights

Aimee Dessinges has built an impressive career, working for notable companies in the pharmaceutical industry, including Les Laboratoires Servier and Adir Et Compagnie. Her experience in these organizations has allowed her to refine her skills and contribute effectively to significant pharmaceutical advancements.

Collaborations

Throughout her career, Aimee has collaborated with esteemed colleagues such as Jean-Louis Peglion and Bertrand Goument. These collaborations have fostered a dynamic research environment that has led to groundbreaking innovations in the pharmaceutical sector.

Conclusion

Aimee Dessinges stands as an influential figure in the pharmaceutical industry, with her 14 patents underscoring her commitment to innovation and research. Her work continues to impact the field and improve therapeutic options available for treating various medical conditions. As she forges ahead in her career, the contributions of Aimee Dessinges promise to leave a lasting legacy in the world of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com